Ezetimibe and low density lipoprotein subfractions: an ongoing debate.
| Title | Ezetimibe and low density lipoprotein subfractions: an ongoing debate. |
| Publication Type | Journal Article |
| Year of Publication | 2011 |
| Authors | Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. |
| Journal | Curr Med Res Opin |
| Volume | 27 |
| Issue | 3 |
| Pagination | 693-5 |
| Date Published | 2011 Mar |
| ISSN | 1473-4877 |
| Keywords | Anticholesteremic Agents, Azetidines, Chemical Fractionation, Cholesterol, Cholesterol, LDL, Dissent and Disputes, Humans, Hypercholesterolemia, Lipoproteins, LDL, Particle Size, Prognosis, Simvastatin |
| Abstract | There is evidence that small dense low density lipoprotein (sdLDL) subfractions are more atherogenic than buoyant LDL. Therefore, it is relevant to assess the effect of lipid lowering drugs on LDL subfractions. In this editorial we discuss the effect of ezetimibe (EZE; a cholesterol transport inhibitor) alone or in combination with a statin, on sdLDL levels. We conclude that, based on currently available evidence, more studies are needed before a definitive answer can be provided regarding the effect of EZE on sdLDL levels. |
| DOI | 10.1185/03007995.2011.554809 |
| Alternate Journal | Curr Med Res Opin |
| PubMed ID | 21275848 |
